Page last updated: 2024-10-20

uric acid and 2019 Novel Coronavirus Disease

uric acid has been researched along with 2019 Novel Coronavirus Disease in 27 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research Excerpts

ExcerptRelevanceReference
"Patients with high baseline serum uric acid levels or who achieved high steady-state serum favipiravir concentrations during therapy were susceptible to hyperuricemia."8.12Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients. ( Doi, Y; Iwasaki, H; Koseki, T; Mizuno, T; Nakajima, K; Takahashi, K; Yamada, S, 2022)
" Subsequently, he showed increased uric acid levels and developed acute gouty arthritis."7.96Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019. ( Hase, R; Ishida, K; Kurata, R; Kurita, T; Mito, H; Muranaka, E, 2020)
"Patients with high baseline serum uric acid levels or who achieved high steady-state serum favipiravir concentrations during therapy were susceptible to hyperuricemia."4.12Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients. ( Doi, Y; Iwasaki, H; Koseki, T; Mizuno, T; Nakajima, K; Takahashi, K; Yamada, S, 2022)
"This study aimed to identify the relationship between abnormal serum uric acid levels or a history of hyperuricemia and COVID-19 severity in the Japanese population."4.12U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force. ( Arimura, K; Chubachi, S; Fukunaga, K; Fukushima, T; Harada, N; Hasegawa, N; Imoto, S; Ishiguro, T; Ishii, M; Kamata, H; Kanai, T; Kimura, A; Kitagawa, Y; Koike, R; Kusumoto, T; Lee, H; Masaki, K; Miyano, S; Morita, A; Murakami, K; Mutoh, Y; Nakagawara, K; Nakano, Y; Namkoong, H; Ogawa, S; Okada, Y; Otake, S; Saito, F; Suzuki, Y; Tanaka, H; Ueda, S; Ueda, T; Watase, M; Yoshiyama, T, 2022)
" Subsequently, he showed increased uric acid levels and developed acute gouty arthritis."3.96Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019. ( Hase, R; Ishida, K; Kurata, R; Kurita, T; Mito, H; Muranaka, E, 2020)
"Seizures in children with coronavirus disease 2019 (COVID-19) were markedly increased during the Omicron variant surge."1.91Afebrile benign convulsions with or without a reversible splenial lesion in two pediatric patients with COVID-19. ( Kim, YO; Lee, YY, 2023)
"Gout is the most common inflammatory arthritis, but was not considered in most COVID-19 and rheumatic diseases reports."1.72Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement. ( Burgos-Vargas, R; García-Maturano, JS; Gómez-Ruiz, C; Mosqueda-Gutiérrez, M; Peláez-Ballestas, I; Tafoya-Amado, A; Torres-Ordaz, DE; Vázquez-Mellado, A; Vázquez-Mellado, J, 2022)
"hyperuricemia has attracted greater attention."1.72Can Uric Acid be Used as a Prognostic Factor to Determine the Severity of Covid 19 Infection. ( Balaraj, K; G, S; Mukherjee, T; Prabhu, R; Sc, R, 2022)
"Novel coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rapidly progressed to a global pandemic."1.62Laboratory Predictors of COVID-19 Mortality: A Retrospective Analysis from Tongji Hospital in Wuhan. ( Dong, L; Gong, Q; Li, X; Liu, X; Wei, Y; Zheng, B; Zheng, T; Zhong, J, 2021)
"The severity of coronavirus disease 2019 (COVID-19) is highly variable between individuals, ranging from asymptomatic infection to critical disease with acute respiratory distress syndrome requiring mechanical ventilation."1.62Serum uric acid, disease severity and outcomes in COVID-19. ( Belkhir, L; De Greef, J; Dufour, I; Gérard, L; Jadoul, M; Laterre, PF; Morelle, J; Perrot, M; Schmit, G; Werion, A; Wisniewska, A; Wittebole, X; Yombi, JC, 2021)

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's27 (100.00)2.80

Authors

AuthorsStudies
Li, G2
Wu, X2
Zhou, CL1
Wang, YM1
Song, B1
Cheng, XB1
Dong, QF1
Wang, LL1
You, SS1
Ba, YM1
García-Maturano, JS1
Torres-Ordaz, DE1
Mosqueda-Gutiérrez, M1
Gómez-Ruiz, C1
Vázquez-Mellado, A1
Tafoya-Amado, A1
Peláez-Ballestas, I1
Burgos-Vargas, R1
Vázquez-Mellado, J1
Koseki, T1
Nakajima, K2
Iwasaki, H1
Yamada, S1
Takahashi, K1
Doi, Y1
Mizuno, T1
Hsu, CJ1
Lin, WC1
Chou, YC1
Yang, CM1
Wu, HL1
Cheng, YH1
Liu, PC1
Chang, JY1
Chen, HY1
Sun, JR1
G, S1
Balaraj, K1
Prabhu, R1
Mukherjee, T1
Sc, R1
Abhishek, A1
Cipolletta, E1
Nakafero, G1
Avery, AJ1
Mamas, M1
Tata, LJ1
Gruszka, K1
Terlecki, M1
Klocek, M1
Drożdż, T1
Rajzer, M1
Fukushima, T1
Chubachi, S1
Namkoong, H1
Otake, S1
Nakagawara, K1
Tanaka, H1
Lee, H1
Morita, A1
Watase, M1
Kusumoto, T1
Masaki, K1
Kamata, H1
Ishii, M1
Hasegawa, N1
Harada, N1
Ueda, T1
Ueda, S1
Ishiguro, T1
Arimura, K1
Saito, F1
Yoshiyama, T1
Nakano, Y1
Mutoh, Y1
Suzuki, Y1
Murakami, K1
Okada, Y1
Koike, R1
Kitagawa, Y1
Kimura, A1
Imoto, S1
Miyano, S1
Ogawa, S1
Kanai, T1
Fukunaga, K1
Inanc, IH1
Sabanoglu, C1
Wu, Y2
Liu, J2
Liu, S1
Fan, W1
Ding, C1
Gao, Z2
Tang, Z1
Luo, Y1
Shi, X2
Tan, L1
Song, S1
Majumder, N1
Deepak, V1
Hadique, S1
Aesoph, D1
Velayutham, M1
Ye, Q2
Mazumder, MHH1
Lewis, SE1
Kodali, V1
Roohollahi, A1
Guo, NL1
Hu, G1
Khramtsov, VV1
Johnson, RJ1
Wen, S1
Kelley, EE1
Hussain, S1
Lin, Y1
Ma, B1
Yang, Y2
Chen, Y5
Huang, J2
Li, W3
Yu, X1
Liang, L1
Jatuworapruk, K3
Satpanich, P3
Robinson, PC3
Grainger, R3
Wen, YF1
Culhane-Pera, KA1
Pergament, SL1
Moua, Y1
Vue, B1
Yang, T3
Lo, M1
Sun, B2
Knights, D1
Straka, RJ1
Lee, YY1
Kim, YO1
Abdellatif, A1
Zhao, L1
Chamberlain, J1
Cherny, K1
Xin, Y1
Marder, BA1
Scandling, JD1
Saag, K1
Cimmino, G1
Gallinoro, E1
di Serafino, L1
De Rosa, G1
Sugraliyev, A1
Golino, P1
Cirillo, P1
Xu, Q1
Li, F2
Chen, X2
Mishima, E1
Anzai, N1
Miyazaki, M1
Abe, T1
Ni, X1
Sun, C1
Tian, Y1
Huang, Y2
Gong, T1
Song, L1
Yang, X3
Li, K1
Zheng, N1
Wang, J6
Wu, H1
Zhang, R1
Wang, Y3
Wang, G1
Qin, J1
Jing Liang, J1
Ye, B1
Li, N1
Wang, X6
Tang, M1
Shao, J1
Hase, R1
Kurata, R1
Ishida, K1
Kurita, T1
Muranaka, E1
Mito, H1
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H4
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X11
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Zhang, E1
Zhang, J3
Li, Y6
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X2
Ren, Y1
Li, J7
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L3
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y4
Lu, J2
Li, M2
Wu, W1
Du, F1
Ji, H1
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y3
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liu, Z2
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y4
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X2
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X4
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B2
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q2
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q2
Song, W1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Zheng, T1
Zheng, B1
Dong, L1
Zhong, J1
Hu, F1
Guo, Y1
Lin, J1
Zeng, Y1
Cong, L1
Lu, C1
Gu, HQ1
Zhang, G1
Lio, J1
Hu, Y1
Lan, X1
Chen, Z1
Pan, H1
Dufour, I1
Werion, A1
Belkhir, L1
Wisniewska, A1
Perrot, M1
De Greef, J1
Schmit, G1
Yombi, JC1
Wittebole, X1
Laterre, PF1
Jadoul, M1
Gérard, L1
Morelle, J1

Reviews

2 reviews available for uric acid and 2019 Novel Coronavirus Disease

ArticleYear
Uric Acid Elevation by Favipiravir, an Antiviral Drug.
    The Tohoku journal of experimental medicine, 2020, Volume: 251, Issue:2

    Topics: Aldehyde Oxidase; Amides; Antiviral Agents; Biotransformation; Coronavirus Infections; COVID-19; Dru

2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021

Trials

3 trials available for uric acid and 2019 Novel Coronavirus Disease

ArticleYear
Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol.
    PloS one, 2023, Volume: 18, Issue:2

    Topics: Adult; Ascorbic Acid; Clinical Trials, Phase II as Topic; COVID-19; Gout; Gout Suppressants; Humans;

2023
Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial.
    Clinical transplantation, 2023, Volume: 37, Issue:9

    Topics: Adult; COVID-19; Gout; Gout Suppressants; Humans; Kidney Transplantation; Middle Aged; Polyethylene

2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021

Other Studies

23 other studies available for uric acid and 2019 Novel Coronavirus Disease

ArticleYear
Uric acid as a prognostic factor and critical marker of COVID-19.
    Scientific reports, 2021, 09-07, Volume: 11, Issue:1

    Topics: Adult; Aged; Biomarkers; China; COVID-19; Feasibility Studies; Female; Hospital Mortality; Humans; K

2021
Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement.
    Clinical rheumatology, 2022, Volume: 41, Issue:3

    Topics: Allopurinol; COVID-19; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pandemics; Prospective St

2022
Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 115

    Topics: Amides; COVID-19; Humans; Hyperuricemia; Pyrazines; SARS-CoV-2; Uric Acid

2022
Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

    Topics: Animals; COVID-19; Cricetinae; Disease Models, Animal; Humans; Lipoproteins, LDL; Lung; Male; Mesocr

2022
Can Uric Acid be Used as a Prognostic Factor to Determine the Severity of Covid 19 Infection.
    The Journal of the Association of Physicians of India, 2022, Volume: 70, Issue:4

    Topics: Adolescent; Adult; COVID-19; Female; Humans; Hyperuricemia; Male; Middle Aged; Prognosis; Retrospect

2022
Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink.
    Annals of the rheumatic diseases, 2022, Volume: 81, Issue:12

    Topics: Allopurinol; Cohort Studies; COVID-19; Gout; Gout Suppressants; Humans; Pandemics; Uric Acid

2022
[Ocena związku stężenia kwasu moczowego z przebiegiem zakażenia SARS-CoV-2].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2022, Jun-24, Volume: 50, Issue:297

    Topics: C-Reactive Protein; Cardiovascular Diseases; COVID-19; Humans; Hyperuricemia; Retrospective Studies;

2022
U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122

    Topics: Cohort Studies; COVID-19; Humans; Hyperuricemia; Japan; Risk Factors; Uric Acid

2022
Autonomic dysfunction and metabolic disorders as the possible sequelae of COVID-19 infection.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:15

    Topics: Autonomic Nervous System Diseases; Blood Pressure Monitoring, Ambulatory; COVID-19; Exercise Test; F

2022
Bromoacetic acid causes oxidative stress and uric acid metabolism dysfunction via disturbing mitochondrial function and Nrf2 pathway in chicken kidney.
    Environmental toxicology, 2022, Volume: 37, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Chickens; COVID-19; Kelch-Like ECH

2022
Redox imbalance in COVID-19 pathophysiology.
    Redox biology, 2022, Volume: 56

    Topics: Antioxidants; COVID-19; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrogen Peroxi

2022
Impaired kidney function biomarkers and risk of severe COVID-19: Analysis of population-based cohort data.
    Molecular genetics & genomic medicine, 2022, Volume: 10, Issue:11

    Topics: Adult; Albuminuria; Biomarkers; COVID-19; Cross-Sectional Studies; Cystatin C; Genetic Predispositio

2022
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
    The Journal of rheumatology, 2023, Volume: 50, Issue:4

    Topics: Adult; COVID-19; COVID-19 Testing; Gout; Gout Suppressants; Humans; Polymerase Chain Reaction; Preva

2023
Afebrile benign convulsions with or without a reversible splenial lesion in two pediatric patients with COVID-19.
    BMC pediatrics, 2023, 04-26, Volume: 23, Issue:1

    Topics: Child; COVID-19; Fever; Humans; Infant, Newborn; Magnetic Resonance Imaging; SARS-CoV-2; Seizures; U

2023
Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes.
    Internal and emergency medicine, 2023, Volume: 18, Issue:6

    Topics: Acute Coronary Syndrome; Biomarkers; C-Reactive Protein; Coronary Artery Disease; COVID-19; Endothel

2023
Factors Affecting Mortality in Elderly Hypertensive Hospitalized Patients with COVID-19: A Retrospective Study.
    Clinical interventions in aging, 2023, Volume: 18

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; COVID-19; Frailty; Hospital Mortality; Humans; Hyperte

2023
Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?
    Science China. Life sciences, 2020, Volume: 63, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Blood Gluco

2020
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
    Diabetes research and clinical practice, 2020, Volume: 167

    Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Betacoronavirus; Blood Urea Nitrogen; C-Rea

2020
Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019.
    Internal medicine (Tokyo, Japan), 2020, Sep-15, Volume: 59, Issue:18

    Topics: Adult; Amides; Antiviral Agents; Arthritis, Gouty; Betacoronavirus; Coronavirus Infections; COVID-19

2020
Laboratory Predictors of COVID-19 Mortality: A Retrospective Analysis from Tongji Hospital in Wuhan.
    Mediators of inflammation, 2021, Volume: 2021

    Topics: Adult; Aged; Biomarkers; China; COVID-19; Cytokines; Female; Humans; Hyperuricemia; Inflammation Med

2021
Association of serum uric acid levels with COVID-19 severity.
    BMC endocrine disorders, 2021, May-08, Volume: 21, Issue:1

    Topics: Adult; Aged; Body Mass Index; Case-Control Studies; COVID-19; Creatinine; Female; Glomerular Filtrat

2021
Serum Uric Acid Concentrations and Risk of Adverse Outcomes in Patients With COVID-19.
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: Adult; Aged; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Ma

2021
Serum uric acid, disease severity and outcomes in COVID-19.
    Critical care (London, England), 2021, 06-14, Volume: 25, Issue:1

    Topics: Aged; Belgium; Cohort Studies; COVID-19; Critical Illness; Humans; Kidney Tubules, Proximal; Male; M

2021